These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 11156818

  • 1. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine.
    Kapur S, Roy P, Daskalakis J, Remington G, Zipursky R.
    Am J Psychiatry; 2001 Feb; 158(2):311-4. PubMed ID: 11156818
    [Abstract] [Full Text] [Related]

  • 2. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.
    Kapur S, Zipursky R, Jones C, Remington G, Houle S.
    Am J Psychiatry; 2000 Apr; 157(4):514-20. PubMed ID: 10739409
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
    Talvik M, Nordström AL, Nyberg S, Olsson H, Halldin C, Farde L.
    Am J Psychiatry; 2001 Jun; 158(6):926-30. PubMed ID: 11384901
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
    Tuppurainen H, Kuikka JT, Viinamäki H, Husso M, Tiihonen J.
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):529-37. PubMed ID: 19496999
    [Abstract] [Full Text] [Related]

  • 6. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 7. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D.
    Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
    [Abstract] [Full Text] [Related]

  • 8. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
    Kapur S, Zipursky R, Jones C, Shammi CS, Remington G, Seeman P.
    Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
    [Abstract] [Full Text] [Related]

  • 9. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
    Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S.
    Am J Psychiatry; 1998 Jul; 155(7):921-8. PubMed ID: 9659858
    [Abstract] [Full Text] [Related]

  • 10. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S, Seeman P.
    Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
    [Abstract] [Full Text] [Related]

  • 11. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S, Tatsch K, Dähne I, Mager T, Scherer J, Hahn K.
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [Abstract] [Full Text] [Related]

  • 12. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
    Mamo D, Kapur S, Shammi CM, Papatheodorou G, Mann S, Therrien F, Remington G.
    Am J Psychiatry; 2004 May; 161(5):818-25. PubMed ID: 15121646
    [Abstract] [Full Text] [Related]

  • 13. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.
    Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G.
    Arch Gen Psychiatry; 1992 Jul; 49(7):538-44. PubMed ID: 1352677
    [Abstract] [Full Text] [Related]

  • 14. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R, Okumura M, Ito H, Takano A, Takahashi H, Takano H, Maeda J, Okubo Y, Suhara T.
    J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
    [Abstract] [Full Text] [Related]

  • 15. A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.
    Remington G, Mamo D, Labelle A, Reiss J, Shammi C, Mannaert E, Mann S, Kapur S.
    Am J Psychiatry; 2006 Mar; 163(3):396-401. PubMed ID: 16513859
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Atypical antipsychotics, tardive dyskinesia, and D(2) receptors.
    Duggal HS, Mendhekar DN.
    Am J Psychiatry; 2006 Aug; 163(8):1449-50. PubMed ID: 16877664
    [No Abstract] [Full Text] [Related]

  • 18. Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine.
    Markianos M, Hatzimanolis J, Lykouras L, Christodoulou GN.
    Schizophr Res; 2002 Jul 01; 56(1-2):11-7. PubMed ID: 12084414
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
    Graff-Guerrero A, Rajji TK, Mulsant BH, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Gerretsen P, Mar W, Pollock BG, Mamo DC.
    JAMA Psychiatry; 2015 Sep 01; 72(9):927-34. PubMed ID: 26131622
    [Abstract] [Full Text] [Related]

  • 20. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P, Tallerico T.
    Mol Psychiatry; 1998 Mar 01; 3(2):123-34. PubMed ID: 9577836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.